In the final part of her interview, Margrit Wiesendanger, MD, PhD, discusses the need to improve lupus care by addressing social determinants of health and expanding access to treatment.
Margrit Wiesendanger, MD, PhD
Advertisement
Margrit Wiesendanger, MD, PhD, is a clinical rheumatologist who treats patients with a range of diagnoses, including lupus, and serves as the program director for rheumatology fellowship training within the Mount Sinai Health System. She also co-directs the "Foundations of Immunology and Microbiology" course at the Icahn School of Medicine at Mount Sinai.
Articles by Margrit Wiesendanger, MD, PhD
Margrit Wiesendanger, MD, PhD, highlights how social determinants of health and equitable treatment access are critical to improving lupus outcomes, particularly in minority populations.
Margrit Wiesendanger, MD, PhD, discusses how lupus treatment is evolving from traditional therapies to more targeted options like biologics, with promising advances now being explored in clinical trials.
Margrit Wiesendanger, MD, PhD, explores lupus symptoms, diagnosis challenges, and the importance of early detection to prevent inflammation-related damage.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
In Its 50th Year, ESMO Comes to Berlin, a City Transformed
2
Physical Activity, Vaccination May Protect Against Long COVID
3
CVS Pharmacy Completes Acquisition of Select Rite Aid Locations
4
Medicare State Rankings Reveal Stark Differences in Access, Quality, and Affordability
5
